Durgical
EN
Open the app

Nitazoxanide

  • Other antiprotozoalsOther antiprotozoals

Oral broad-spectrum antiparasitic for diarrhoea caused by Giardia and Cryptosporidium; well tolerated, it may tint the urine.

Updated

Quick facts

Group
Other antiprotozoals
Target
Pyruvate-ferredoxin oxidoreductase (PFOR) of anaerobic protozoa and bacteria
Used for
Diarrhoea caused by Giardia · Intestinal amoebiasis
Key effects
Abdominal pain · Headache · Nausea
Monitor
Number of stools and hydration
ATC
P01AX11

No doses: the clinician sets them by the current guideline.

Mechanism of action

A nitrothiazolyl-salicylamide. In the gut it is quickly hydrolysed to tizoxanide, its active metabolite. Tizoxanide interferes with the electron-transfer reaction of pyruvate-ferredoxin oxidoreductase (PFOR), an enzyme that anaerobic protozoa such as Giardia and Cryptosporidium need to make energy from pyruvate; humans do not use this enzyme. It also acts on Entamoeba histolytica, some helminths and some anaerobic bacteria.

  1. Hydrolysed to active tizoxanide
  2. Blocks electron transfer by PFOR
  3. Anaerobic energy metabolism fails
  4. Giardia and Cryptosporidium die

Indications

Adverse effects

Common

  • Abdominal pain
  • Headache
  • Nausea
  • Discoloured (greenish-yellow) urine

Contraindications

  • Hypersensitivity to nitazoxanide
  • Caution: liver or kidney disease

Key interactions

Other medicines and supplements
No major interactions are named in patient information; all medicines are still reviewed before starting

What is monitored

  • Number of stools and hydration
  • Clinical response after the short course; in immunocompromised people, response is often incomplete
  • Stool tests when diarrhoea persists

Administration and safety

  • Oral tablets or suspension, with food, as a short course.
  • The suspension is shaken well; unused suspension is discarded after a set number of days.
  • Fluids are given to prevent dehydration.

Pregnancy and breastfeeding

Generally considered low risk in pregnancy, but human data are limited and the prescriber weighs the need.

Nursing care

  • Assess hydration (weight, urine output, mucous membranes) in children with diarrhoea.
  • Explain that the urine may change colour and that this is harmless.
  • Teaching: drink plenty of fluids, finish the course and wash hands well to avoid spreading the parasite.
  • Report persistent diarrhoea, especially in people with HIV or other immune problems.

Pharmacokinetics

Absorption
Oral; rapidly converted to tizoxanide; taken with food
Distribution
Tizoxanide is more than 99.9 % bound to plasma proteins
Metabolism
Hydrolysis to tizoxanide, then glucuronide conjugation
Elimination
Urine, bile and faeces

Test yourself

Think of the answer, then tap the question to see it.

Which two protozoa are nitazoxanide's main targets?

Giardia (giardiasis) and Cryptosporidium (cryptosporidiosis).

Which enzyme does its active metabolite inhibit?

Pyruvate-ferredoxin oxidoreductase (PFOR), needed for the energy metabolism of anaerobic protozoa.

In which patients is it less effective against Cryptosporidium?

In immunocompromised people, such as those with advanced HIV; restoring immune function is the key measure.

Add to my cards (3)

More Pharmacology questions →

Connections

← Back to the class: Other antiprotozoals

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Nitazoxanide: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.